Abstract 5241: p38 MAPK/EGR1/PD-L1 axis promotes radiation resistance of nasopharyngeal carcinoma by enhancing immune evasion

Dong-Fang Meng

DOI: https://doi.org/10.1158/1538-7445.am2022-5241

IF: 11.2

2022-06-17

Cancer Research

Abstract:Radiation resistance is the main reason for treatment failure. Till present, the underlying molecular mechanism of NPC radiation resistance remains poorly understood. Recent clinical trials have demonstrated that PD-1/PD-L1 inhibitors have achieved better efficacy in the treatment of recurrent or metastatic NPC. Further studies are needed to better understand the molecular mechanisms underlying PD-1/PD-L1 inhibitors enhance response to radiation in NPC. We performed RNA-seq analysis in NPC radioresistant and wild-type cells. We identified EGR1 promotes NPC radiation resistance and is significantly correlated with NPC recurrence. We further found that EGR1 upregulated PD-L1 expression at transcriptional level in a p38 MAPK dependent manner. Moreover, EGR1 participated in CD8+T cell mediated immune evasion in NPC radioresistant cells. We therefore propose a hypothesis that p38 MAPK/EGR1 axis induced PD-L1 expression promotes radiation resistance of NPC by enhancing immune evasion. This study aims to identify the key regulatory factors in p38 MAPK/EGR1/PD-L1 axis, especially PD-L1, as a new target to improve radiosensitivity of NPC, provide theoretical basis for PD-1/PD-L1 inhibitors plus radiotherapy in the treatment of NPC. Meanwhile, this study also provides the possibility for predicting the radiosensitivity of NPC. Citation Format: Dong-Fang Meng. p38 MAPK/EGR1/PD-L1 axis promotes radiation resistance of nasopharyngeal carcinoma by enhancing immune evasion [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 5241.

oncology